Health Technology/clinical-trials

First Prospective Cohort Trial of At-Home tDCS Neuromodulation for Menstrual and Perimenopausal Mood Symptoms Opens Recruitment — Implications for Occupational Health and Women's Wellbeing

247 Health News Editorial

·

17 July 2026

·

5 min read

·clinical-trials

A new US-based prospective cohort trial (NCT07679074) is recruiting employed women with menstrual, perimenopausal, or menopausal mood and cognitive symptoms to evaluate a 12-week digital care program combining at-home tDCS neuromodulation with app-based coaching. The study uses validated occupational health instruments — the WPAI and EQ-5D-5L — to assess impact on workforce productivity and quality of life, with implications for employer-sponsored women's health programs globally.

Originally reported by ClinicalTrials.gov

References

  1. 1.Samphire Group, Inc. (2025). A 12-week prospective cohort study evaluating the efficacy of the Samphire Guided Care Program on wellbeing, work productivity, and quality of life in individuals with menstrual and pelvic health conditions (NCT07679074). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07679074
  2. 2.Brunoni, A. R., Nitsche, M. A., Bolognini, N., Bikson, M., Wagner, T., Merabet, L., Edwards, D. J., Valero-Cabre, A., Rotenberg, A., Pascual-Leone, A., Ferrucci, R., Priori, A., Boggio, P. S., & Fregni, F. (2012). Clinical research with transcranial direct current stimulation (tDCS): Challenges and future directions. Brain Stimulation, 5(3), 175–195. https://doi.org/10.1016/j.brs.2011.03.002
  3. 3.Lefaucheur, J. P., Antal, A., Ayache, S. S., Benninger, D. H., Brunelin, J., Cogiamanian, F., Cotelli, M., De Ridder, D., Ferrucci, R., Langguth, B., Marangolo, P., Mylius, V., Nitsche, M. A., Padberg, F., Palm, U., Poulet, E., Priori, A., Rossi, S., Schecklmann, M., … Paulus, W. (2017). Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS). Clinical Neurophysiology, 128(1), 56–92. https://doi.org/10.1016/j.clinph.2016.10.087
  4. 4.Reilly, M. C., Zbrozek, A. S., & Dukes, E. M. (1993). The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics, 4(5), 353–365. https://doi.org/10.2165/00019053-199304050-00006
  5. 5.Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727–1736. https://doi.org/10.1007/s11136-011-9903-x
  6. 6.Armour, M., Parry, K., Manohar, N., Holmes, K., Ferfolja, T., Curry, C., MacMillan, F., & Smith, C. A. (2019). The prevalence and academic impact of dysmenorrhea in 21,573 young women: A systematic review and meta-analysis. Journal of Women's Health, 28(8), 1161–1171. https://doi.org/10.1089/jwh.2018.7615
  7. 7.Agarwal, S. K., Chapron, C., Giudice, L. C., Laufer, M. R., Leyland, N., Missmer, S. A., Singh, S. S., & Taylor, H. S. (2019). Clinical diagnosis of endometriosis: A call to action. American Journal of Obstetrics and Gynecology, 220(4), 354.e1–354.e12. https://doi.org/10.1016/j.ajog.2019.01.004
Share:XLinkedIn
2

247 Health News Editorial

247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service